TABLE 3.

IGA from baseline to Week 16 with E-BPO versus vehicle cream: Percent of patients achieving a score of “clear” or “almost clear”

TIME POINT	TREATMENT 1-2 (n=15)	TREATMENT 2-1 (n=16)
Baseline	0	0
Week 2	64.29	12.50
Week 4	85.71	31.25
Week 8	78.57	37.50
Week 12	78.57	80.00
Week 16	78.57	71.43
Range	0–85.71	0–80.00

E-BPO: microencapsulated benzoyl peroxide cream, 5%; IGA: Investigator Global Assessment